Two professors at National Taiwan University yesterday unveiled a nonintrusive way to evaluate the effect of treatment on patients suffering from leukemia.
Tiffany Shih (施庭芳), chairwoman of the department of radiology at the university’s College of Medicine told a press conference that she, professor Tien Hwei-fang (田蕙芬) and their research team had created an innovative model to analyze the effect of leukemia treatment through the use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI).
“Traditionally, doctors need to rely on bone marrow punctures to assess the condition of patients suffering leukemia. However, [through this technique] doctors can only obtain a small number of [cell] samples and patients have to endure the pain of the punctures,” Shih said.
“I had been wondering how we could develop a nonintrusive approach,” she said, adding that she found the answer in DCE-MRI after six years of research.
Shih said doctors would be able to get a large amount of blood flow data from patients by having them take between 10ml and 20ml of an MRI contrast agent before taking a five-minute MRI scan.
“The scan is fast, nonintrusive and can be taken frequently [unlike bone marrow punctures],” she said.
Doctors would be able to access the degree of angiogenesis — the formation of new blood vessels — inside patients’ bone marrow and evaluate the effect of leukemia treatment, she said.
“Blood vessels are to cancer cells what soil is to seeds. Without the new vessels, it would be impossible for cancer cells to receive the nutrients they need,” she said.
Although the new technique would not completely replace bone marrow punctures in leukemia diagnosis, she said, doctors could obtain more information on their patients’ condition at an earlier stage of the illness.
The DCE-MRI technique could also be used to help review the effect of treatment for other types of cancer — such as liver cancer — that involve angiogenesis, she said.
The technique can also be used by doctors to determine whether to give aggressive treatment to patients who have suffered a stroke, she said, adding that doctors would be able to diagnose a patient’s brain cell vitality by evaluating blood flow data.
Shih said the university had completed clinical tests and that the technique would be covered by the National Health Insurance.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS